CTRI/2023/03/050358招募中Unknown
Identification of resistance markers to PARP inhibitors
试验速览
- 阶段
- Unknown
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients with confirmed malignant carcinoma of the breast, ovary and prostate who are eligible for PARP inhibitor therapy and will be undergoing PARP inhibitor therapy as identified by the site Principal Investigator or co-Investigators through routine clinical care processes
- •2. Age - 18 years and above
- •3. Both men and women of all races and ethnic groups are eligible for this study
- •4. New, relapsed, recurrent cases
- •5. Ability to understand and the willingness to sign a written Informed Consent Form
排除标准
- •1. Pregnant or lactating women
- •2. Patients who have an uncontrolled infection
- •3. Patients who are receiving any additional oncology investigational agent(s) with PARP inhibitors
- •4. Patients who are coagulopathic and are taking blood thinning products
研究者
相似试验
进行中（未招募）
不适用
A study to characterise mechanisms of resistance to PARP inhibitors by analysing samples from women with ovarian cancerHigh-grade ovarian cancerMalignant neoplasm of ovaryCancerISRCTN59698923HS Greater Glasgow and Clyde260
尚未招募
不适用
Identification of serum markers mediating resistance to sunitinib in patients with renal cell carcinomarenal cell carcinomaJPRN-UMIN000004374Kobe University Graduate school of Medicine100
尚未招募
Unknown
Discovery of molecular signatures to understand the response of Immuno-oncology drugsCTRI/2023/09/057273Strand Life Sciences Pvt Ltd
已完成
不适用
Genotypic and Phenotypic Correlates of Resistance to AspirinPlatelet Dysfunction Due to AspirinNCT01361620George Washington University190
已完成
不适用
Monitoring of Anti-Malarial Drug resistance by real-time quantitative nucleic acid sequence-based amplification and the impact on TRANSmission of Plasmodium falciparumMalariaISRCTN31291803The Netherlands Foundation for the Advancement of Tropical Research (NWO-WOTRO) (The Netherlands)500